Respirerx Pharmaceuticals (OTCMKTS:RSPI) Shares Down 10%
Respirerx Pharmaceuticals Inc (OTCMKTS:RSPI)’s stock price fell 10% during mid-day trading on Tuesday . The company traded as low as $0.20 and last traded at $0.20, 6,138 shares traded hands during trading. A decline of 19% from the average session volume of 7,581 shares. The stock had previously closed at $0.22.
The stock’s 50-day simple moving average is $0.34 and its 200-day simple moving average is $0.60.
Respirerx Pharmaceuticals Company Profile (OTCMKTS:RSPI)
RespireRx Pharmaceuticals Inc engages in the discovery and development of pharmaceuticals for the treatment of respiratory disorders. The company has two drug platforms comprising ampakines that act to enhance the actions of the excitatory neurotransmitter glutamate at AMPA glutamate receptors; and cannabinoids, primarily dronabinol, a synthetic derivative for use in refractory chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS.
Recommended Story: What is the 52-week high/low?
Receive News & Ratings for Respirerx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Respirerx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.